Company / Revenue
Solventum Revenue History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$8.3B
FY2025
5-year range
$8.1B / $8.3B
FY2022-FY2025
Trend
+0.9%
vs FY2024
Sector context
#30 of 156
Health Care
What the data says
Solventum's revenue of $8.3B is higher than 81% of companies in the Health Care sector (FY2025). Revenue has increased for 3 consecutive years, from $8.1B in FY2022 to $8.3B in FY2025.
Based on SEC 10-K filings.
$8.3B in FY2025 with a 3-year CAGR of +0.8%. Top quartile in the Health Care sector.
Remained stable around $8.3B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +0.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 156This company $8.3B Sector average $19.0B
▼
-56.2% below sector average
Key checks
Key Insights
- Solventum's revenue has grown for 3 consecutive years.
- 3-year CAGR of +0.8%, indicating consistent growth.
- In FY2025, revenue increased 0.9% year-over-year.
- Ranks #30 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.3B | +0.9% |
| FY2024 | $8.3B | +0.7% |
| FY2023 | $8.2B | +0.8% |
| FY2022 | $8.1B | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026